Entrada Therapeutics
This role supports the early commercial strategy team by synthesizing and communicating strategic insights to prepare for commercial launch. The position involves conducting market research, competitive intelligence, and forecasting analysis to drive key strategic decisions. The ideal candidate will combine analytical skills with a deep understanding of the life sciences business to generate actionable insights.
Headquarters
Boston, Massachusetts, United States
Company Size
51-200 employees
Founded
2016
Entrada Therapeutics is a biotechnology company focused on enabling intracellular therapeutics by solving the problem of getting large molecules into cells to reach intracellular targets. They develop proprietary delivery technologies intended to expand access to previously “undruggable” intracellular targets and transform treatment options for devastating genetic and other diseases. Entrada advances its own therapeutic programs and collaborates with partners to translate its platform into clinically meaningful medicines.
Entrada Therapeutics (NASDAQ:TRDA) Hits New 1-Year High - Time to Buy?
2 days ago
Earnings Preview: Entrada Therapeutics, Inc. (TRDA) Q4 Earnings Expected to Decline
3 weeks ago
Analysts Offer Insights on Healthcare Companies: Entrada Therapeutics Inc (TRDA), Kymera Therapeutics (KYMR) and Argenx Se (ARGX)
2 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Entrada Therapeutics.
Entrada Therapeutics, Inc. (TRDA) Reports Q3 Loss, Misses Revenue Estimates
Nov 6, 2025
Sr. Manager - Oncology Forecasting & Insights
Pfizer
Director, Integrated Insights and Strategy, Thoracic
Pfizer
Associate Director, Commercial Strategy and Insights
MapLight Therapeutics
Competitive Intelligence Analyst
Novartis
Associate Director, Early Commercial Strategy and Insights
Dianthus Therapeutics
Category Insights Lead
Cargill, Incorporated